EUVIMEDEUVIMED entdecken
Crossref

One Eyelid, A Thousand Faces

K. Sbai K. Sbai, Y. Hidan Y. Hidan, A. Aneddame A. Aneddame

IOSR Journal of Dental and Medical Sciences · 2026-07 · 25 (7) · 51-52

DOI: 10.9790/0853-2507015152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IOSR Journal of Dental and Medical Sciences, 2026-07. Verfasst von K. Sbai K. Sbai und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cutaneous leishmaniasis (CL) is characterized by significant clinical polymorphism. Its occurrence in the eyelid remains rare and can be misleading. Case Report: We report the case of a 49-year-old male patient receiving corticosteroid therapy and immunosuppressants for an autoimmune bullous dermatosis. He presented with recurrent bilateral eyelid swellings initially labeled as multiple chalazions. Given the failure of conventional treatments and the appearance of multiple indurated nodules along the free margin, an excisional biopsy was performed. Histological and parasitological examination revealed Leishmania bodies, confirming eyelid CL.

Conclusion

In the presence of any atypical or refractory chalazion, particularly in endemic areas or in an immunocompromised patient, the diagnosis of cutaneous leishmaniasis should be considered to avoid therapeutic missteps.

Zitieren

APA

Sbai, K. S. K., Hidan, Y. H. Y., & Aneddame, A. A. A. (2026). One Eyelid, A Thousand Faces. IOSR Journal of Dental and Medical Sciences, 25(7), 51-52. https://doi.org/10.9790/0853-2507015152

Vancouver

Sbai KSK, Hidan YHY, Aneddame AAA. One Eyelid, A Thousand Faces. IOSR Journal of Dental and Medical Sciences. 2026;25(7):51-52. doi:10.9790/0853-2507015152

BibTeX
@article{Sbai2026,
  author = {Sbai, K. Sbai K. and Hidan, Y. Hidan Y. and Aneddame, A. Aneddame A.},
  title = {One Eyelid, A Thousand Faces},
  journal = {IOSR Journal of Dental and Medical Sciences},
  year = {2026},
  volume = {25},
  number = {7},
  pages = {51--52},
  doi = {10.9790/0853-2507015152}
}
Kostenlos starten →